Root cause medicine: When the treatment never asked why

You went to the doctor for low energy and you left with a prescription for something to help you sleep. You went back for weight gain and you left with advice to eat less. You went a third time for brain fog and you were told your labs were normal. Nothing was measured beyond the basics, so nothing underneath the symptoms was ever found. That experience is not a failure of your doctor's intelligence or your own. It is what happens when a medical system pays for visits instead of for answers and it is the gap root cause medicine exists to close.

Root cause medicine asks why a problem exists before it decides what to prescribe. Instead of managing each symptom separately, the clinician measures the systems underneath it, such as insulin resistance, lipids, inflammation, thyroid function and hormones and treats what the results actually show. This article explains what that looks like in practice, why the conventional visit almost never does it and what it costs to be treated this way in 2026.

The visit that never asked why

Consider the standard arc of a chronic complaint in American primary care. The visit runs seven to fifteen minutes. The clinician orders the panel the practice template includes, which is usually a basic metabolic screen and a complete blood count. If your glucose is under the diabetic threshold and your thyroid stimulating hormone is inside the reference range, the visit ends with a prescription for the symptom or an instruction to return in six months.

Here is what that structure cannot see. A glucose in the high-normal range says nothing about the fasting insulin that has been climbing for years to hold it there. A TSH in range says nothing about free T3, free T4 or thyroid antibodies and a thyroid that is in range but not right is one of the most common findings in a patient who has been told nothing is wrong. A standard lipid panel says nothing about ApoB, the particle count that carries the atherosclerotic risk or about Lp(a), a genetic risk factor measured once in a lifetime for most people who ever get it measured at all.

Neither column is bad medicine. The left column is what a fifteen-minute visit can finish. The right column is what the question actually requires and the gap between the two is where years of undiagnosed insulin resistance, subclinical thyroid dysfunction and silent cardiovascular risk live.

Why the system is built this way

It helps to be precise about the villain here, because the villain is not your doctor. Fee-for-service billing pays a practice for visits, procedures and prescriptions. It does not pay meaningfully for the hour a thoughtful physician would spend tracing fatigue back to insulin resistance, sleep disruption and a thyroid panel nobody ordered. Under that structure, the practice that orders deep panels and reads them carefully loses money on every patient it does well by. The seven-minute visit is not laziness. It is the shape the incentive system carved.

There is a second constraint. Most practices inherit their lab panel from an electronic health record template designed for the average patient and the average patient visit is a sick visit rather than a diagnostic investigation. Ordering ApoB, Lp(a), fasting insulin and a full thyroid panel on every physical would be clinically reasonable and economically irrational inside that model. So the template ships with what the model can afford and patients with real, findable problems walk out with a normal lab report and a referral nowhere.

This is why we describe our own model as aligned rather than as clever. A membership fee of $299 a month buys the time and the panels that a visit-based model cannot afford to give. The fee includes a comprehensive Biomarker Audit every 90 days, four per year, run through the Beluga Health lab network. Because the fee does not depend on prescriptions, no one here earns more when you take more medication and no one earns more when your dose climbs. The financial structure has to be right before the clinical philosophy can be, which is why we talk about the money as openly as we talk about the labs.

What finding a root cause actually changes

The difference is not philosophical. It changes what gets prescribed and what stops being prescribed. Consider three patients whose complaints would fill the same fifteen-minute visit.

The first arrives with weight that will not move. Under symptom management, the answer is diet advice and perhaps a prescription. Under root cause medicine, the panel shows fasting insulin at 28 and HbA1c at 5.9, which is insulin resistance driving the plateau and the treatment becomes measurement-guided weight management with a branded GLP-1 where indicated, alongside nutrition and activity, with the panels repeated every 90 days to confirm the insulin trajectory is actually bending.

The second arrives with fatigue, poor sleep and low mood. Symptom management offers three prescriptions, one per complaint. The panel shows a TSH at the top of the reference range with a low free T3 and elevated antibodies, which is a thyroid that is in range but not right and the treatment becomes thyroid care guided by the full panel rather than a sedative.

The third arrives with a family history of early heart disease and a clean bill of health. The routine physical says fine. ApoB comes back elevated and Lp(a) comes back high and suddenly there is a decade of warning before the event anyone was waiting for, with time to act. The American Heart Association has stated that ApoB provides a more accurate measure of circulating atherogenic particles than LDL cholesterol alone and none of the three patients above would have been found by the template.

What it costs, in a market that hides its prices

Because this is the part most readers of a piece like this one actually want to know, we will put it plainly and early. The Cardiometabolic Optimization Membership is $299 a month. At sign-up, $598 is held on your card and covers the first two months combined. If a clinician cannot accept you into care, the hold is released and you are never charged. Once you are accepted, those first two months are non-refundable and from month three the membership runs month to month at $299 with no long-term contract. A full year of this care, including four Biomarker Audits, comes to $3,588.

For comparison, executive health and longevity programs commonly report assessments from several thousand dollars up to more than twenty thousand dollars a year and most of them sell diagnostics rather than ongoing care. You receive a report and then you are on your own for the treatment. A labs-only membership at $365 a year gives you the panel and no physician to read it with you. A concierge retainer commonly reported between roughly $2,000 and $5,000 a year buys you more time with a doctor but rarely includes the deep panel at all.

What our model does differently is unbundle the medicine from the fee. When a branded GLP-1 or bioidentical hormone therapy is clinically indicated, your pharmacy bills it at its own price and we set nothing on it. One flat fee for the doctor. Zero markup on the medicine. The membership and the pharmacy bill are two separate charges and that separation is the whole integrity of the model.

Who we are, in one paragraph

Clinical care is delivered by licensed physicians of Beluga Health, P.A., an independent Florida professional corporation licensed in all 50 states, working under GoodLife Health's clinical protocols. Care is telehealth and labs-first: the eligibility check, the intake, the first Biomarker Audit and then a conversation with a clinician who has read the results. Prescriptions are written for branded, FDA-approved medication only, including Wegovy, Zepbound, Ozempic, Mounjaro, Wegovy Tablets and Foundayo for medical weight loss and bioidentical hormone optimization where the hormone panel indicates it. Compounded GLP-1s are never prescribed here under any circumstance.

If you want the model explained from first principles, What Is GoodLife Health? Direct Primary Care, Explained covers it in full. For the diagnostic centerpiece of the model, read The Biomarker Audit, Explained. And for the arithmetic of the offer against every alternative, The Real ROI of a $299/Month Health Membership runs it with dated figures.

FAQ

What is root cause medicine?

Root cause medicine is a clinical approach that asks why a symptom or diagnosis exists before choosing a treatment. The clinician measures the systems underneath the problem, such as insulin resistance, lipids, inflammation, thyroid function and hormones and treats what the results show rather than prescribing for each complaint separately.

Is root cause medicine the same as functional medicine?

The two overlap in philosophy but differ in structure and evidence. Functional medicine is a specific framework with its own training and often long supplement protocols. Our version is more conventional: a comprehensive biomarker panel read by a licensed physician against your history, followed by FDA-approved treatment where the results indicate it. No supplement stack is required.

Why doesn't my regular doctor practice root cause medicine?

Most primary care visits are built around a seven to fifteen minute window and a billing system that pays for visits rather than for diagnostic depth. A physician in that structure can manage what is urgent but rarely has the time or the panel budget to trace a symptom back to insulin resistance, thyroid function or hormone levels. It is usually a system constraint rather than an effort problem.

What labs are part of a root cause workup?

Our Biomarker Audit measures ApoB, Lp(a), hs-CRP, HbA1c, a full lipid panel, fasting insulin markers and complete hormone and thyroid panels every 90 days. Together those markers describe blood sugar, cardiovascular risk, inflammation and hormonal function as one connected system.

How much does root cause medicine cost?

Prices vary widely by provider. Executive and longevity programs commonly report assessments from several thousand to over twenty thousand dollars a year, usually for diagnostics alone. Our membership is $299 a month or $598 at sign-up covering the first two months, with four Biomarker Audits a year included and medication billed separately by your pharmacy at its own price.

Can root cause medicine replace my medications?

Sometimes and only with a physician's judgment. Improving insulin resistance through measurable biomarker change can reduce the need for some medications over time, but that decision belongs to your clinician and your prescribing doctor, never to an article. We measure first and adjust based on what follow-up panels show.

How long does it take to see results?

Lab markers move on different timelines. HbA1c reflects roughly the prior three months of blood sugar, hs-CRP can shift within weeks and lipids usually respond over one to three months. The quarterly cadence exists so that change is measured rather than guessed at.

Related Reading

• What Is GoodLife Health? Direct Primary Care, Explained
• The Biomarker Audit, Explained
• The Real ROI of a $299/Month Health Membership

References

1. Atherosclerotic Cardiovascular Disease Risk Assessment With Apolipoprotein B (American Heart Association scientific statement). 2022. www.ahajournals.org/doi/10.1161/ATV.0000000000000174
2. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). 2021. pubmed.ncbi.nlm.nih.gov/33567185/
3. Standardization of Thyroid Function Testing (American Thyroid Association guidelines). 2023. www.thyroid.org/professionals/ata-professional-guidelines/clinical-therapy-guidelines/thyroid-dysfunction-guidelines/